While ideological opponents continue to do everything they can to eliminate Medicare Advantage, the research evidence continues to show benefits from the program over traditional fee-for-service Medicare. (NBER Paper) To avoid selection bias issues which might result from unobservably healthier beneficiaries enrolling in Medicare Advantage, the authors used a feature of Medicare Advantage payments that gives higher reimbursement to plans in counties with populations over 250,000 as a basis for analysis. While it is generally unquestioned that Medicare pays Medicare Advantage more for a particular beneficiary than that beneficiary would cost in traditional Medicare, that is an intentional political decision that Congress made. Whether or not more is actually spent on their care is a different question, as is the issue of comparative quality. At this point, there appears to be accumulating evidence that quality is better in Medicare Advantage plans. And there is more evidence than not that there is lower utilization, particularly of low-value services, in the Medicare Advantage plans. The authors try to extend these analyses by finding a way to eliminate unknown variables between the Medicare Advantage and fee-for-service populations. They compared outcomes from beneficiaries in counties with populations from 100,000 to 249,999 to counties with populations from 250,000 to 400,000 persons. They incorporate beneficiary and country characteristics into their analysis. The larger, higher Medicare Advantage reimbursement counties have more Medicare Advantage enrollment, as might be expected. After all the adjustments, the analysis shows over a 20% reduction in hospital admissions for Medicare Advantage, along with lower mortality, demonstrating once again that Medicare Advantage plans are likely delivering more appropriate care, usually with better outcomes.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
September 24, 2023
Relative Spending and Utilization for Medicare Advantage Plans
Medicare Advantage plans have lower utilization and spending than does the Medicare fee-for-service program.
Commentary
September 23, 2023
Stop-loss Insurance Claims for Self-funded Employers
A report on stop-loss insurance reveals increases in number of claims and average cost of…
Commentary
September 22, 2023
Coronamonomania Lives Forever, Part 224
From far across the Pacific comes yet another set of summaries, just like the virus.